The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - Novo Nordisk (NYSE:NVO) already set a new 52-week high this week of $167.74, and shares are poised to again break that high Friday. A European … Continue Reading
Read nowResearch - We continue to believe that shares of Elan Corp. (NYSE:ELN) are trading at a premium valuation, given ongoing speculation that partner Biogen-Idec (NASDAQ:BIIB) may acquire … Continue Reading
Read nowLong Ideas - Huntington’s disease is an inherited neurodegenerative disorder that leads to the progressive degeneration of nerve cells in the brain. The disease is genetic in nature … Continue Reading
Read nowMost Popular - Geron Corp (NASDAQ:GERN) may have finally found a buyer for its suspended stem cell program. The company has been searching since November of 2011 when … Continue Reading
Read nowMost Popular - Shares of Amarin, plc (NASDAQ:AMRN)Â were highly volatile in early afternoon trading Thursday as an article written in the P&T Journal, published on a National … Continue Reading
Read nowQuick Picks - In an all-stock merger announced Thursday morning, BioCryst Pharmaceuticals (NASDAQ:BCRX) will acquire privately-held Presidio, Inc, creating a new business entity to focus on oral Hepatitis … Continue Reading
Read nowLong Ideas - After being decimated earlier this year on the FDA rejection of Northera, shares of Chelsea Therapeutics (NASDAQ:CHTP) could be rejuvenated as new Phase III results … Continue Reading
Read now
